Jefferies Discusses Array BioPharma (ARRY) After Detailed Selumetinib Ph2 Data in NSCLC
Go back to Jefferies Discusses Array BioPharma (ARRY) After Detailed Selumetinib Ph2 Data in NSCLC| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 11.01 -0.16 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.17 | 52 Week High | $7.27 | |||
| Open | $11.20 | 52 Week Low | $2.39 | |||
| Day High | $11.32 | P/E | N/A | |||
| Day Low | $10.88 | EPS | $-0.61 | |||
| Volume | 2,929,001 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 68.45 -0.08 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.53 | 52 Week High | $35.04 | |||
| Open | $68.25 | 52 Week Low | $26.97 | |||
| Day High | $68.79 | P/E | N/A | |||
| Day Low | $68.16 | EPS | $0.00 | |||
| Volume | 1,903,693 | |||||
